Gates Foundation announces investments to advance mRNA vaccine research and manufacturing

At the 2023 Grand Challenges Annual Meeting, Bill Gates, Co-chair of the Bill & Melinda Gates Foundation, announced new investments to advance access to mRNA research and vaccine manufacturing technology that will support low- and middle-income countries’ (LMICs) capacity to develop high-quality, lifesaving vaccines at scale.

Bruntwood SciTech set to invest £60m into Manchester Science Park – Lifescience Industry News

Bruntwood SciTech is set to invest a further £60m into Manchester Science Park (MSP) and support the creation of over 2,500 jobs, as it unveils

March 7, 2023

These 10 scientists are leading a new generation of gene editors developing CRISPR medicines

Barely 12 years after the publication of the first papers unveiling CRISPR-Cas9, a powerful enzyme for editing DNA, sickle cell patients are now receiving the

October 31, 2024

Formycon and Fresenius Kabi reach settlement agreement for ustekinumab biosimilar candidate FYB202 in Europe and Canada – Biotech Investments

EQS-News: Formycon AG / Key word(s): Agreement Formycon and Fresenius Kabi reach settlement agreement for ustekinumab biosimilar candidate FYB202 in Europe and Canada 18.03.2024 /

March 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.